Dr. Sardar Z Imam
Claim this profileSan Juan Oncology Associates
Studies Gastroesophageal Junction Adenocarcinoma
Studies Squamous Cell Carcinoma
3 reported clinical trials
5 drugs studied
Area of expertise
1Gastroesophageal Junction Adenocarcinoma
metastatic
locally advanced
Stage IV
2Squamous Cell Carcinoma
metastatic
locally advanced
extensive stage
Affiliated Hospitals
Clinical Trials Sardar Z Imam is currently running
Disitamab Vedotin + Tucatinib
for Breast Cancer
This clinical trial is studying solid tumor cancers. A solid tumor is one that starts in part of your body like your lungs or liver instead of your blood. Once they've grown bigger in one spot or spread to other parts of the body, they're harder to treat. This is called advanced or metastatic cancer. Participants in this study must have breast cancer or gastric cancer. Participants must have tumors that have HER2 on them. This allows the cancer to grow more quickly or spread faster. There are few treatment options for patients with advanced or metastatic solid tumors that express HER2. This clinical trial uses an experimental drug called disitamab vedotin (DV). Disitamab vedotin is a type of antibody drug conjugate or ADC. ADCs are designed to stick to cancer cells and kill them. This clinical trial uses a drug called tucatinib, which has been approved to treat cancer in the United States and some other countries. This drug is sold under the brand name TUKYSA®. This study will test how safe and how well DV, with or without tucatinib, is for participants with solid tumors. This study will also test what side effects happen when participants take these drugs. A side effect is anything a drug does to the body besides treating the disease.
Recruiting1 award Phase 1 & 26 criteria
SEA-CD70
for Myelodysplastic Syndrome and Acute Myeloid Leukemia
This trial is testing a new drug, SEA-CD70, alone and with azacitidine, to see if it is safe and works for adults with certain blood cancers that haven't responded to other treatments. The study will determine the best dose and check for side effects. Azacitidine is a treatment that improves survival, reduces the need for transfusions, and lowers the risk of progression to acute myeloid leukemia in patients with higher risk myelodysplastic syndromes.
Recruiting1 award Phase 110 criteria
More about Sardar Z Imam
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Sardar Z Imam has experience with
- Pembrolizumab
- Ladiratuzumab Vedotin
- SEA-CD70
- Disitamab Vedotin
- Tucatinib
Breakdown of trials Sardar Z Imam has run
Gastroesophageal Junction Adenocarcinoma
Squamous Cell Carcinoma
Esophageal Carcinoma
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sardar Z Imam specialize in?
Sardar Z Imam focuses on Gastroesophageal Junction Adenocarcinoma and Squamous Cell Carcinoma. In particular, much of their work with Gastroesophageal Junction Adenocarcinoma has involved metastatic patients, or patients who are locally advanced.
Is Sardar Z Imam currently recruiting for clinical trials?
Yes, Sardar Z Imam is currently recruiting for 2 clinical trials in Farmington New Mexico. If you're interested in participating, you should apply.
Are there any treatments that Sardar Z Imam has studied deeply?
Yes, Sardar Z Imam has studied treatments such as Pembrolizumab, Ladiratuzumab Vedotin, SEA-CD70.
What is the best way to schedule an appointment with Sardar Z Imam?
Apply for one of the trials that Sardar Z Imam is conducting.
What is the office address of Sardar Z Imam?
The office of Sardar Z Imam is located at: San Juan Oncology Associates, Farmington, New Mexico 87401 United States. This is the address for their practice at the San Juan Oncology Associates.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.